Joseph Bailes
Director/Board Member bij TerSera Therapeutics LLC
Oorsprong van het eerstegraads netwerk van Joseph Bailes
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 22 | |
TerSera Therapeutics LLC
TerSera Therapeutics LLC Medical SpecialtiesHealth Technology TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL.
5
| Holding Company | Medical Specialties | 5 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.
4
| Non-Profit Organization | Medical/Nursing Services | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Joseph Bailes via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
ALBANY MOLECULAR RESEARCH, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
VARIAN MEDICAL SYSTEMS, INC. | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
EXELIXIS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Waratah Pharmaceuticals, Inc.
Waratah Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Part of OPKO Health, Inc., Waratah Pharmaceuticals, Inc. develops pharmaceutical products. The private company is based in Calgary, Canada. The Canadian company was founded by Susan Dana Jones. Waratah Pharmaceuticals was acquired by Transition Therapeutics, Inc., part of OPKO Health, Inc. from September 01, 2016 on January 28, 2002 for $15.46 million. | Medical Specialties | Founder | |
ImmuRx, Inc.
ImmuRx, Inc. BiotechnologyHealth Technology ImmuRx, Inc. develops adjuvant platforms for the treatment of cancer and infectious disease. Its product includes CD40 compound, an antibody. The company was founded by Randolph J. Noelle and Ross Kedl in 2005 and is headquartered in Lebanon, NH. | Biotechnology | Chief Tech/Sci/R&D Officer | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Graduate Degree Graduate Degree | |
GTCR LLC
GTCR LLC Investment ManagersFinance GTCR LLC (GTCR) is a private equity firm founded in 1980 by Charlie Thomas. The firm is headquartered in Chicago, Illinois. | Investment Managers | Chief Executive Officer Private Equity Investor | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Cole-Parmer Instrument Co. LLC
Cole-Parmer Instrument Co. LLC Medical SpecialtiesHealth Technology Antylia Scientific provides laboratory and industrial fluid handling products, instrumentation, equipment, and supplies. The firm's services include calibration services, custom-blend chemicals, custom cut-to-lenght tubing, custom single-use bioprocess assemblies, custom temperature probes, on-site calibration services and special and custom orders. The company was founded by Jerry Cole and John Parmer in January 1955 and is headquartered in Vernon Hills, IL. | Medical Specialties | Director/Board Member Director/Board Member | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Colgate University | College/University | Undergraduate Degree Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
CBR Systems, Inc.
CBR Systems, Inc. Medical/Nursing ServicesHealth Services CBR Systems, Inc. engages in the provision of newborn stem cell company. Its clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today. The company was founded by Thomas E. Moore, Jesse O. Kramer, Wendy K. Grant, Paul R. Billings and Stephen M. Grant in 1992 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
XIFIN, Inc.
XIFIN, Inc. Packaged SoftwareTechnology Services XIFIN, Inc. engages as a healthcare information technology company. Its products and services include revenue cycle management, laboratory information systems, precision medicine informatics, and digital pathology consultation. The company was founded by L?le White, Donald Lavigne, Michael Coats, and Jeffrey Yates in 1997 and is headquartered in San Diego, CA. | Packaged Software | Director/Board Member Director/Board Member | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Devicor Medical Products, Inc.
Devicor Medical Products, Inc. Financial ConglomeratesFinance Devicor Medical Products, Inc. engages in acquiring medical device companies and products. Its products include mommotome revolve, elite, tissue markers, neoprene, specimen radiograph, mammo test and stereo solutions. The company was founded in 2008 and is headquartered in Cincinnati, OH. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Actient Pharmaceuticals LLC
Actient Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Actient Pharmaceuticals LLC develops and markets pharmaceutical therapeutic products. The company was founded in March 2009 and is headquartered in Malvern, VA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
Vall d'Hebron Institut d'Oncologia
Vall d'Hebron Institut d'Oncologia Miscellaneous Commercial ServicesCommercial Services Vall d'Hebron Institut d'Oncologia specializes in the treatment of sarcoma, a rare type of cancer that originates from mesenchymal cells. The non-profit company is based in Barcelona, Spain. Sarcoma is a diverse group of cancers that can be classified into two categories based on their genetic alterations. The first category includes sarcomas that are driven by simple genetic alterations such as translocations or specific activating mutations. The second category includes sarcomas with complex and unbalanced genomic aberrations. | Miscellaneous Commercial Services | Director/Board Member | |
Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree | |
Crealta Pharmaceuticals LLC
Crealta Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Crealta Pharmaceuticals LLC operates as a specialty pharmaceutical company. The firm pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas. The company was founded in August 2013 and is headquartered in Lake Forest, IL. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Financial Conglomerates | Director/Board Member Director/Board Member | |
REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Director of Finance/CFO | |
ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Canyon Holdings (Cayman) LP
Canyon Holdings (Cayman) LP Investment ManagersFinance Canyon Holdings (Cayman) LP operates as a pooled investment fund. The company was incorporated in 2014 and is headquartered in Chicago, IL. | Investment Managers | Director/Board Member Director/Board Member | |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Founder Founder | |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Venthera, Inc.
Venthera, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Venthera, Inc. develops biopharmaceuticals. The private company is based in Palo Alto, CA. The company was founded by José Baselga. | Pharmaceuticals: Major | Founder | |
ELIEM THERAPEUTICS, INC. | Biotechnology | General Counsel | |
Corza Health, Inc.
Corza Health, Inc. Packaged SoftwareTechnology Services Corza Health, Inc. develops healthcare platform for life sciences and medical technology sectors. The company was founded in 2019 and is headquartered in San Diego, CA. | Packaged Software | Director/Board Member Director/Board Member | |
WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
TURMERIC ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
MARAVAI LIFESCIENCES HOLDINGS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The private company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
Verenigde Staten | 46 |
Ierland | 3 |
Canada | 2 |
Spanje | 2 |
Sectoraal
Health Technology | 25 |
Consumer Services | 9 |
Finance | 8 |
Commercial Services | 6 |
Health Services | 4 |
Operationeel
Director/Board Member | 207 |
Corporate Officer/Principal | 75 |
Independent Dir/Board Member | 55 |
Founder | 32 |
Chief Tech/Sci/R&D Officer | 27 |
Sterkste connecties
Insiders | |
---|---|
Luke Evnin | 42 |
Dean Mihas | 35 |
Ron Hunt | 29 |
José Baselga | 27 |
Alan Colowick | 27 |
Mark Chin | 25 |
Benjamin J. Daverman | 21 |
Patrick Baeuerle | 19 |
Scott Myers | 18 |
Joanne Viney | 18 |
Georgia Erbez | 18 |
Sandra Horning | 14 |
Lauren Silvernail | 14 |
Natalie Sacks | 13 |
Gerald McMahon | 13 |
- Beurs
- Insiders
- Joseph Bailes
- Bedrijfsconnecties